MX394238B - Proceso de cultivo celular - Google Patents

Proceso de cultivo celular

Info

Publication number
MX394238B
MX394238B MX2018012129A MX2018012129A MX394238B MX 394238 B MX394238 B MX 394238B MX 2018012129 A MX2018012129 A MX 2018012129A MX 2018012129 A MX2018012129 A MX 2018012129A MX 394238 B MX394238 B MX 394238B
Authority
MX
Mexico
Prior art keywords
cell culture
culture process
polyvinylalcohol
pva
tyrosine
Prior art date
Application number
MX2018012129A
Other languages
English (en)
Other versions
MX2018012129A (es
Inventor
Bruno Figueroa
Wenge Wang
Yen- Tung Luan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2018012129A publication Critical patent/MX2018012129A/es
Publication of MX394238B publication Critical patent/MX394238B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La presente invención se refiere a un medio de cultivo celular que comprende tirosina a una concentración de al menos 3 mM y alcohol polivinilico (PVA).
MX2018012129A 2016-04-05 2017-03-23 Proceso de cultivo celular MX394238B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662318275P 2016-04-05 2016-04-05
PCT/IB2017/051692 WO2017175086A1 (en) 2016-04-05 2017-03-23 Cell culture process

Publications (2)

Publication Number Publication Date
MX2018012129A MX2018012129A (es) 2018-12-17
MX394238B true MX394238B (es) 2025-03-19

Family

ID=58503669

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018012129A MX394238B (es) 2016-04-05 2017-03-23 Proceso de cultivo celular

Country Status (17)

Country Link
US (2) US20190112572A1 (es)
EP (1) EP3440190B1 (es)
JP (2) JP7253923B2 (es)
KR (1) KR102168981B1 (es)
CN (1) CN109415688B (es)
AU (1) AU2017247701B2 (es)
CA (1) CA3019753C (es)
ES (1) ES2992543T3 (es)
HR (1) HRP20241328T1 (es)
IL (1) IL261999B2 (es)
MX (1) MX394238B (es)
PL (1) PL3440190T3 (es)
RU (1) RU2709378C1 (es)
SG (1) SG11201808356UA (es)
SI (1) SI3440190T1 (es)
WO (1) WO2017175086A1 (es)
ZA (1) ZA201806295B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111748527B (zh) * 2020-05-15 2021-01-29 上海多宁生物科技有限公司 化学成分限定高效补料培养基及其制备方法和应用
CN111676184B (zh) * 2020-05-15 2021-01-29 上海多宁生物科技有限公司 一种由补料培养基共混的基础培养基及其制备方法和应用
US20230034857A1 (en) * 2020-09-15 2023-02-02 Lg Chem, Ltd. Microcarrier for cell culture and method for preparing the same
KR102864804B1 (ko) * 2020-09-15 2025-09-25 주식회사 엘지화학 세포 배양용 마이크로-캐리어 및 그 제조방법
EP4426814A2 (en) 2021-11-01 2024-09-11 Vertex Pharmaceuticals Incorporated Stem cell derived pancreatic islet differentiation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS494454B1 (es) * 1970-08-24 1974-02-01
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
CA2067194C (en) 1989-10-05 2003-03-18 Glenn Kawasaki Cell-free synthesis and isolation of novel genes and polypeptides
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
US6900056B2 (en) 2001-02-15 2005-05-31 Centocor, Inc. Chemically defined medium for cultured mammalian cells
PL224001B1 (pl) 2002-05-02 2016-11-30 Wyeth Corp Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
EP1812557A4 (en) * 2004-10-29 2009-11-04 Centocor Ortho Biotech Inc COMPOSITIONS OF CHEMICALLY DEFINED MEDIA
BRPI0613770A2 (pt) 2005-07-22 2009-05-19 Y S Therapeutics Co Ltd anticorpos anti-cd26 e métodos de uso destes
ES2538986T3 (es) * 2006-11-08 2015-06-25 Wyeth Llc Medios diseñados racionalmente para un cultivo celular
RU2377295C1 (ru) * 2008-06-11 2009-12-27 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Питательная среда для культивирования клеток млекопитающих
RU2644651C2 (ru) * 2010-04-26 2018-02-13 Новартис Аг Среда для культивирования клеток
PT3485903T (pt) 2011-09-23 2023-02-17 Mereo Biopharma 5 Inc Agentes de ligação a vegf/dll4 e utilizações dos mesmos

Also Published As

Publication number Publication date
CA3019753C (en) 2021-10-26
RU2709378C1 (ru) 2019-12-17
MX2018012129A (es) 2018-12-17
KR102168981B1 (ko) 2020-10-22
HRP20241328T1 (hr) 2024-12-20
CN109415688B (zh) 2022-08-02
IL261999B (en) 2022-12-01
ZA201806295B (en) 2019-07-31
US20190112572A1 (en) 2019-04-18
JP2022022475A (ja) 2022-02-04
JP7253923B2 (ja) 2023-04-07
AU2017247701A1 (en) 2018-10-04
IL261999A (en) 2018-10-31
IL261999B2 (en) 2023-04-01
PL3440190T3 (pl) 2024-12-02
JP2019510499A (ja) 2019-04-18
AU2017247701B2 (en) 2022-11-10
EP3440190B1 (en) 2024-08-28
WO2017175086A1 (en) 2017-10-12
SG11201808356UA (en) 2018-10-30
CN109415688A (zh) 2019-03-01
EP3440190A1 (en) 2019-02-13
KR20180117189A (ko) 2018-10-26
US20230416674A1 (en) 2023-12-28
SI3440190T1 (sl) 2025-01-31
BR112018070063A2 (pt) 2019-02-12
ES2992543T3 (es) 2024-12-13
CA3019753A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
MX394238B (es) Proceso de cultivo celular
CL2021000704A1 (es) Anticuerpos contra proteína alfa reguladora de señal y métodos de uso. (divisional de solicitud 668-2019)
CL2020001954A1 (es) Determinación de biomasa de pescado, forma y tamaño
EP3460042A4 (en) CELL CULTURE MEDIUM FOR ORGANOID CULTURE, CULTURE METHOD AND ORGANOID
EA201992795A1 (ru) Способ получения эукариотических клеток с отредактированной днк и набор, используемый в этом способе
AR119878A2 (es) Composiciones y métodos para detectar un contaminante biológico
EA201992001A1 (ru) Композиции и способы повышения экспрессии генов
EA201890137A1 (ru) Среда для культивирования клеток с добавлением таурина и способы применения
UY37055A (es) Composiciones inoculantes estables y métodos para su producción
EP3418376A4 (en) CELL CULTURE MEDIUM, CULTURAL PROCESS AND ORGANOID
EA202192126A3 (ru) Способы сбора культур клеток млекопитающих
AR119997A1 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso
EA201791300A1 (ru) Флюидные системы, содержащие канал инкубации, включающие в себя флюидные системы, образованные литьевым формованием
SA518392005B1 (ar) تحديد خصائص التسلسل العميق للأورام
EA201690718A1 (ru) Способ обработки целлюлозосодержащей биомассы
EP3581642A4 (en) FLUID CHIP INTENDED FOR USE IN CELL CULTURE, CULTURE CONTAINER, AND CULTURE PROCESS
MX378388B (es) Biorreactores de pequeño volumen con volumenes de trabajo sustancialmente constantes y sistemas y metodos relacionados.
CL2017003309A1 (es) Métodos de purificación y/o inactivación viral
MX2021011609A (es) Moduladores de interacciones de proteinas de superficie celular y metodos y composiciones relacionados con estos.
MX2017012223A (es) Metodo de produccion con iones de cobre controlados.
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
AR112851A1 (es) Procedimiento para la obtención de una glicoproteína con un mayor porcentaje de glicanos afucosilados
EA201691542A1 (ru) Перфузионная среда
EP4361255A4 (en) CELL CULTURE METHOD, CELL CULTURE KIT AND CELL CULTURE SYSTEM
MX2019006783A (es) Procedimiento para la preparacion de 4-amino-1-( (1s, 4r, 5s) -2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirim idin-2-ona.